A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Marijuana and its CD4 Receptors: A New HIV Treatment Strategy?
Pathway to a Cure: Cancer Drug Helps Purge HIV From Resting Cells
Life Expectancy With HIV Increases Dramatically
Undetectable Viral Load? Not Necessarily in Semen
Engineering CD8 Cells to Kill HIV in Tissues
Pathway to a Cure: Positive Results Continue for Sangamo's CCR5 Gene Therapy
Revised U.S. Guidelines: HIV Treatment is Recommended for All People Living With HIV
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailprint

November 7, 2011

Low Levels of HIV in the Blood Aren’t Connected to Inflammation or Death

Low-level viremia—HIV in the bloodstream in amounts below the level measured by standard tests—is not associated with inflammation or death, according to a November 2 study on PLoS One. The researchers, based at the San Francisco VA Medical Center and the University of California at San Francisco, found that the increased immune activation and coagulation (blood thickening) experienced by people living with HIV and taking antiretroviral medications (ARVs) are not caused by such viremia. This finding, senior investigator Phyllis Tien, MD, said in an accompanying announcement, “means that we need to focus on other possible mechanisms by which HIV increases inflammation and coagulation.”

Previous research has shown that HIV-positive people whose virus is suppressed by ARVs still experience increased immune activation and inflammation, which can elevate the risk of cardiovascular disease (CVD), clotting and stroke. The cause has remained unclear, leading some to assume that it results from the low-level viremia documented in people whose HIV registers undetectable (50 to 75 viral copies per milliliter of blood, depending on which test is used).

In the current study, the researchers write, they expected to find an association between low-level viremia and certain biomarkers known to indicate increased risk of CVD and mortality. Instead, they found no correlation between such low-level viremia and the three biomarkers—elevated interleukin (IL-6, a protein related to inflammation), fibrinogen (a protein involved in clotting) and C-reactive protein (CRP also related to inflammation). They did, however, find that higher levels of HIV in the blood (above 10,000 copies per milliliter, substantially above the level of undetectable) were associated with increases in two biomarkers: IL-6 and fibrinogen.

The research was conducted on blood samples from 1,116 HIV-positive people in the Study of Fat Redistribution and Metabolic Changes in HIV Infection (FRAM), a long-term study of people living with HIV in the United States. The samples were scrutinized using a newly approved test from Roche Molecular Diagnostics, capable of detecting HIV levels below 20 copies per milliliter. In addition to the findings regarding IL-6, CRP and fibrinogen, the tests found no association between low-level viremia and increased risk of death.

The researchers caution that their study has limitations, including that it was observational, that the blood plasma samples available for testing were small (possibly calling into question the readings of less than 20 copies per milliliter), that biomarkers were measured at only two points in time, and that information on cause of death was lacking.

Their findings, they write, suggest the need for further research to determine the specific ways that HIV promotes inflammation and increased risk of mortality. The research also suggests the need to reinvestigate some assumptions. For one thing, they write, the fact that they found no association between CRP and HIV levels could call into question the significance of C-reactive protein as a reliable marker of HIV inflammation.

Search: San Francisco VA Medical Center, University of California at San Francisco, viremia, coagulation, blood thickening, cardiovascular disease, clotting, stroke, blood


Scroll down to comment on this story.

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Ellis, Fort Lauderdale, 2011-11-09 12:45:46
Hi i have had a colesterol up to 600 took some meds that i was alragic to fond one a could take got it under 200 stoped taken the drug about 6yrs. ago know its atarted to climb a little over 200 for now i well keep an eye on my colesterol.poz 23yrs.Ellis

ellis, Lake ridg,Fort Lauderdale,Fl., 2011-11-09 12:23:34
My best friend and partner J.Verberg passed on 10/10/10 of a attack in his sleep and he was hiv neg.49 yrs.He crying for help from docters they kept giveing him antibiotic's 3 t0 4 kinds and the whole time it was his hart. He went to the doc's he went to the hosbital he had health insuranse!I have aids 24yrs.I had 6 Tcells know 900Tcells in the last year after his death i have had marsa,pre-cancer I alargic to steroids that broke my body!alargic to sulfor drogs! allmost put me out for good!!!Eri

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    AnnaMarie528
    Austin
    Texas


    newlife202
    JOLIET
    Illinois


    RoyalPurple
    Las Vegas
    Nevada


    posattitude2011
    Williamstown,NJ
    New Jersey
Click here to join POZ Personals!
Conference Coverage

19th Conference on Retroviruses and Opportunistic Infections (CROI 2012)
Seattle, Washington
March 5 - 8, 2012


6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


more conference coverage

[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.